NL-OMON30229尚未招募不适用
Somatostatin receptor scintigraphy in patients with multiple myeloma or plasmocytoma - Octreotide scan in multiple myeloma.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Upfront patients with MM that are treated according to the HOVON-49 or HOVON-65 protocol.
- •-Upfront patients with plasmacytoma.
- •-Relapsed MM patients with painful affected areas.
排除标准
- •-Radiotherapy lasting longer than 5 days ago in the last 3 months.
- •-Ineligible to perform a scan.
- •-Age under 18 years.
- •-Pregnancy
- •-Severe kidney-dysfunction
研究者
相似试验
进行中（未招募）
不适用
Radioreceptor therapy with labeled somatostatin analogues in tumors with high expression of somatostatin receptors.Patients with tumors expressing somatostatin receptors.EUCTR2013-002605-65-ITAzienda Ospedaliera di Reggio Emilia Arcispedale S.Maria Nuova/IRCCS
进行中（未招募）
1 期
Assessment of PET for detection of infectious myocarditisEUCTR2019-002716-43-FRCHRU DE NANCY33
进行中（未招募）
1 期
The effectiveness of Octreotide in hereditary hemorrhagic telangiectasia (a.k.a. Rendu-Osler-Weber disease) patients who suffer from gastrointestinal bleeding.EUCTR2018-004179-11-NLRadboudumc38
尚未招募
不适用
Onderzoek naar de effectiviteit van octreotide in hereditary hemorrhagic telangiectasia patiënten metdaarbij gastrointestinale bloedingen.NL-OMON25382Radboudumc38
进行中（未招募）
1 期
The effectiveness of Octreotide in hereditary hemorrhagic telangiectasia(a.k.a. Rendu-Osler-Weber disease) patients who suffer fromgastrointestinal bleeding.EUCTR2018-004179-11-DERadboudumc38